Xlife Sciences AG (SWX:XLS)

Switzerland · Delayed Price · Currency is CHF

24.70

-0.50 (-1.98%)

At close: Jun 22, 2026

Revenue by Segment

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Technology Platforms	148.96K	150.42K	-	-	-
Technology Platforms Growth	-0.97%	-	-	-	-
Unallocated	126.36K	684.46K	652.30K	748.13K	711.65K
Unallocated Growth	-81.54%	4.93%	-12.81%	5.13%	79.34%
Biotechnologies/Therapies	-	-	336.13K	279.85K	113.33K
Biotechnologies/Therapies Growth	-	-	20.11%	146.93%	-
Total	275.31K	834.88K	988.44K	1.03M	824.98K
Total Growth	-67.02%	-15.54%	-3.85%	24.61%	107.90%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Switzerland	275.31K	834.88K	988.44K	1.03M	806.07K
Switzerland Growth	-67.02%	-15.54%	-3.85%	27.53%	103.14%
Total	275.31K	834.88K	988.44K	1.03M	806.07K
Total Growth	-67.02%	-15.54%	-3.85%	27.53%	103.14%